We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Georgia Healthcare Group Plc | LSE:GHG | London | Ordinary Share | GB00BYSS4K11 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 70.80 | 70.00 | 71.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGHG
RNS Number : 3834Q
Georgia Healthcare Group PLC
18 June 2020
FORM 8 (DD)
PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)
Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: Tamar Shagidze (b) Owner or controller of interests and short positions disclosed, if N/A different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. --------------------------------------- (c) Name of offeror/offeree in relation to whose relevant securities this Georgia Healthcare Group PLC (Offeree) form relates: Use a separate form for each offeror/offeree --------------------------------------- (d) Status of person making the disclosure: Person acting in concert with Offeree e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) --------------------------------------- (e) Date dealing undertaken: 17 June 2020 --------------------------------------- (f) In addition to the company in 1(c) above, is the discloser making No disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" --------------------------------------- 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing
Class of relevant security: Ordinary Shares of 1 penny per share Interests Short positions --------------------- -------------------- Number % Number % ------------ ------- ------------ ------ (1) Relevant securities owned and/or controlled: Nil Nil Nil Nil ------------ ------- ------------ ------ (2) Cash-settled derivatives: Nil Nil Nil Nil ------------ ------- ------------ ------ (3) Stock-settled derivatives (including options) and agreements to Nil Nil Nil Nil purchase/sell: ------------ ------- ------------ ------ Nil Nil Nil Nil TOTAL: ------------ ------- ------------ ------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities (including directors' and other employee options) Restricted share awards of the directors of Georgia Healthcare Group PLC subsidiaries over ordinary shares of 1 penny each in Georgia Healthcare Group PLC Director Number Vesting Date % of total issued share capital of Georgia Healthcare Group PLC -------- ------------------ ---------------------- Tamar Shagidze 1,467 1 January 2021 0.01% -------- ------------------ ---------------------- 934 1 January 2022 0.01% -------- ------------------ ---------------------- 1 January 2021- 7,000 1 January 2023 0.01% -------- ------------------ ---------------------- TOTAL 9,401 0.03% -------- ------------------ ----------------------
All interests disclosed in table 2(b) above are subject to a holding period of up to 5 years.
3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)
Class of relevant security Purchase/sale Number of securities Price per unit N/A N/A N/A N/A -------------- --------------------- ---------------
(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit security securities paid/received paid/received N/A N/A N/A N/A N/A ----------------- ------------------------ ----------------------- ----------------------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit security e.g. CFD e.g. opening/closing a securities long/short position, increasing/reducing a long/short position N/A N/A N/A N/A N/A -------------------- ------------------------- ------------------------- --------------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry date Option money relevant description purchasing, securities price per e.g. paid/ security e.g. call selling, to which unit American, received per option varying etc. option European unit relates etc. N/A N/A N/A N/A N/A N/A N/A N/A ------------- ------------- ------------- -------------- ------------- ------------ ------------- (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit N/A N/A N/A N/A N/A -------------------- ----------------------- --------------------- ----------------------- (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) e.g. subscription, conversion Restricted share awards over ordinary Grant of restricted share awards 7,000 Nil shares of 1 penny each in Georgia Healthcare Group PLC --------------------------------- -------- -------------------------------
All interests disclosed in table 3(d) above are subject to a holding period of up to 5 years.
4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" N/A (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" N/A (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO Supplemental Form 8 (SBL) NO --- Date of disclosure: 18 June 2020 Contact name: Mike Oliver ------------- Telephone number: 07801472268 -------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DCCFPMLTMTIBMFM
(END) Dow Jones Newswires
June 18, 2020 05:48 ET (09:48 GMT)
1 Year Georgia Healthcare Chart |
1 Month Georgia Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions